A clinical trial to study the effect of two intracanal medicaments ( Calcium hydroxide and Farnesol ) in teeth with apical periodontitis

Antimicrobial efficiency of Farnesol as an intracanal medicament in patients with apical periodontitis - A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032330

Enrollment

Registered

2021-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K041- Necrosis of pulp

Interventions

Intervention1: Farnesol: Post cleaning and shaping of the root canals, intracanal medicament is taken using lentulospirals and inserted in the canals. 1 coat per root canal. 7 days period of observa

Eligibility

Inclusion criteria

Inclusion criteria: Non vital teeth with apical periodontitis

Exclusion criteria

Exclusion criteria: Medically compromised individuals Vital teeth Large periapical lesions Endo-perio lesions Age 50 years

Design outcomes

Primary

Measure	Time frame
Reduction of microbial loadTimepoint: Baseline values (S1) After cleaning and shaping of root canals (S2) After 7 days of placement of medicament (S3)	—

Secondary

Measure	Time frame
PainTimepoint: Baseline After 24 hours After 7 days	—

Countries

India

Contacts

Public ContactIffat Nasim

Saveetha Dental College, Saveetha University

nasimiffat@gmail.com09940063567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026